Impact of CES1 Genotype on Metabolism of Methylphenidate

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2014

Conditions
Carboxylesterase 1 (CES1) GenotypeCES1 Activity
Interventions
DRUG

Methylphenidate

10 mg as a single dose followed by one blood sample 3 hours post-dose

Trial Locations (1)

2400

Department of Clinical Pharmacology, Bispebjerg University Hospital, Copenhagen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The Ministry of Science, Technology and Innovation, Denmark

OTHER_GOV

collaborator

Mental Health Centre Sct. Hans (Denmark)

UNKNOWN

collaborator

University of Copenhagen

OTHER

collaborator

The Leiden Academic Center for Drug Research (LACDR)

UNKNOWN

collaborator

Duke University

OTHER

lead

Bispebjerg Hospital

OTHER

NCT02147535 - Impact of CES1 Genotype on Metabolism of Methylphenidate | Biotech Hunter | Biotech Hunter